PTG gene deletion causes impaired glycogen synthesis and developmental insulin resistance

被引:90
作者
Crosson, SM
Khan, A
Printen, J
Pessin, JE
Saltiel, AR
机构
[1] Univ Michigan, Sch Med, Inst Life Sci, Dept Med, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Sch Med, Inst Life Sci, Dept Physiol, Ann Arbor, MI 48109 USA
[3] Univ Iowa, Dept Physiol & Biophys, Iowa City, IA 52242 USA
关键词
D O I
10.1172/JCI200317975
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Protein targeting to glycogen (PTG) is a scaffolding protein that targets protein phosphatase la (PP1alpha) to glycogen, and links it to enzymes involved in glycogen synthesis and degradation. We generated mice that possess a heterozygous deletion of the PTG gene. These mice have reduced glycogen stores in adipose tissue, liver, heart, and skeletal muscle, corresponding with decreased glycogen synthase activity and glycogen synthesis rate. Although young PTG heterozygous mice initially demonstrate normal glucose tolerance, progressive glucose intolerance, hyperinsulinemia, and insulin resistance develop with aging. Insulin resistance in older PTG heterozygous mice correlates with a significant increase in muscle triglyceride content, with a corresponding attenuation of insulin receptor signaling. These data suggest that PTG plays a critical role in glycogen synthesis and is necessary to maintain the appropriate metabolic balance for the partitioning of fuel substrates between glycogen and lipid.
引用
收藏
页码:1423 / 1432
页数:10
相关论文
共 56 条
[1]   Cardiac hypertrophy with preserved contractile function after selective deletion of GLUT4 from the heart [J].
Abel, ED ;
Kaulbach, HC ;
Tian, R ;
Hopkins, JCA ;
Duffy, J ;
Doetschman, T ;
Minnemann, T ;
Boers, ME ;
Hadro, E ;
Oberste-Berghaus, C ;
Quist, W ;
Lowell, BB ;
Ingwall, JS ;
Kahn, BB .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (12) :1703-1714
[2]   Pathophysiological role of leptin in obesity-related hypertension [J].
Aizawa-Abe, M ;
Ogawa, Y ;
Masuzaki, H ;
Ebihara, K ;
Satoh, N ;
Iwai, H ;
Matsuoka, N ;
Hayashi, T ;
Hosoda, K ;
Inoue, G ;
Yoshimasa, Y ;
Nakao, K .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (09) :1243-1252
[3]   Altered expression levels and impaired steps in the pathway to phosphatidylinositol 3-kinase activation via insulin receptor substrates 1 and 2 in Zucker fatty rats [J].
Anai, M ;
Funaki, M ;
Ogihara, T ;
Terasaki, J ;
Inukai, K ;
Katagiri, H ;
Fukushima, Y ;
Yazaki, Y ;
Kikuchi, M ;
Oka, Y ;
Asano, T .
DIABETES, 1998, 47 (01) :13-23
[4]  
ARMSTRONG A, 1998, DTSCH BANK RES GLOBA, V1, P1
[5]   PPP1R6, a novel member of the family of glycogen-targetting subunits of protein phosphatase 1 [J].
Armstrong, CG ;
Browne, GJ ;
Cohen, P ;
Cohen, PTW .
FEBS LETTERS, 1997, 418 (1-2) :210-214
[6]   Glycogen synthase deficiency (glycogen storage disease type 0) presenting with hyperglycemia and glucosuria: Report of three new mutations [J].
Bachrach, BE ;
Weinstein, DA ;
Orho-Melander, M ;
Burgess, A ;
Wolfsdorf, JI .
JOURNAL OF PEDIATRICS, 2002, 140 (06) :781-783
[7]   Altered metabolism causes cardiac dysfunction in perfused hearts from diabetic (db/db) mice [J].
Belke, DD ;
Larsen, TS ;
Gibbs, EM ;
Severson, DL .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2000, 279 (05) :E1104-E1113
[8]   Insulin signaling coordinately regulates cardiac size, metabolism, and contractile protein isoform expression [J].
Belke, DD ;
Betuing, S ;
Tuttle, MJ ;
Graveleau, C ;
Young, ME ;
Pham, M ;
Zhang, DF ;
Cooksey, RC ;
McClain, DA ;
Litwin, SE ;
Taegtmeyer, H ;
Severson, D ;
Kahn, CR ;
Abel, ED .
JOURNAL OF CLINICAL INVESTIGATION, 2002, 109 (05) :629-639
[9]   Overexpression of protein targeting to glycogen (PTG) in rat hepatocytes causes profound activation of glycogen synthesis independent of normal hormone- and substrate-mediated regulatory mechanisms [J].
Berman, HK ;
O'Doherty, RM ;
Anderson, P ;
Newgard, CB .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (41) :26421-26425
[10]   Insulin receptor substrate-1 phosphorylation and phosphatidylinositol 3-kinase activity in skeletal muscle from NIDDM subjects after in vivo insulin stimulation [J].
Bjornholm, M ;
Kawano, Y ;
Lehtihet, M ;
Zierath, JR .
DIABETES, 1997, 46 (03) :524-527